pharma-company /Medicinal products /Active ingredients

Rx · PZN 20059544

REMSIMA 40 mg/ml concentrate for preparation of a solution for infusion vial 350mg

German trade nameREMSIMA 40 mg-ml Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche 350mg

Active ingredientInfliximabPharmaceutical formConcentrate for solution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €1,795

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for REMSIMA 40 mg/ml concentrate for preparation of a solution for infusion vial 350mg.

Review purchasing terms

REMSIMA 40 mg/ml concentrate for preparation of a solution for infusion vial 350mg contains the active ingredient Infliximab and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 20059544). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


REMSIMA 40 mg/ml concentrate for preparation of a solution for infusion vial 350mg was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.